US and UK Made Hidden Pacts to Hide Vaccine Reactions
Analysis by Dr. Joseph Mercola Fact Checked May 02, 2023
~ U.S. and U.K. health officials discussed “anaphylactoid reactions” due to COVID-19 shots
and emphasized their “mutual confidentiality agreement” regarding the topic
~ The news was revealed in 57 pages of heavily redacted U.S. Department of Health and
Human Services (HHS) records via a Freedom of Information Act (FOIA) lawsuit
~ A government email exchange from May 14, 2021, also discusses concerns about
administering COVID-19 shots along with other vaccines during pregnancy
~ Preclinical studies for Pfizer’s COVID shots also warned of rhabdomyolysis, which is the
breakdown of skeletal muscles, but the trial reported it was “completed with no safety
concerns”
~ Regulatory filings show Pfizer knew of its shots’ waning effectiveness in April 2021 but
didn’t publicly acknowledge it until late July 2021
1,2
Information Act (FOIA) lawsuit. Initially, Judicial Watch submitted a FOIA request in
August 2021 that specifically asked for:
“All emails sent to and from members of the Vaccines and Related Biological
Products Advisory Committee regarding adverse events, deaths and/or injuries
caused by investigatory vaccines for the prevention or treatment of SARS-CoV-2
and/or COVID-19 currently produced by Pfizer/BioNTech, Moderna and/or
Johnson & Johnson.”
The request was ignored, prompting the lawsuit that ultimately revealed the
confidentiality agreement between U.S. and U.K. regulators. “Why are we engaged in a
secret deal to keep secret information about adverse events related to the vaccines?”
Judicial Watch president Tom Fitton asked. “I just think it’s troubling. The documents
speak for themselves.”
US and UK Officials Make Pact to Keep Safety Issues Quiet
The pact was revealed in a series of email exchanges from December 2020. Initiated by
Jonathan Mogford, policy director of the U.K.’s Medicines and Healthcare Products
Regulatory Agency, and sent to FDA commissioner Janet Woodcock and Peter Marks,
director of the Center for Biologics Evaluation and Research (CBER). Judicial Watch
reported:
“As background, Mogford includes information on “two cases of anaphylactoid
reactions in individuals with a strong past history of allergic reactions….” Marks
replies to Mogford: “It would be very helpful if our Office of Vaccines could
receive additional details [redacted] from MHRA [UK Medicines and Healthcare
Products Regulatory Agency] under the terms of our mutual confidentiality
agreement.”
Mogford later replies, “… attached are [redacted] hope that’s helpful in the
meantime. If I can just remind — information shared under our confidentiality
agreement.”” 3,4,5
An email exchange from May 14, 2021, also discusses concerns about administering
COVID-19 shots along with other vaccines during pregnancy. According to Judicial
Watch:
“The CDC’s Dr. Amanda Cohn emailed Office of Vaccines Research and Review
Director Marion Gruber and Center for Biologics Evaluation and Research
Director Peter Marks with the subject line “Coadministration of COVID-19
Vaccines with Other Vaccines During Pregnancy.”
Gruber writes, “I am fine with this language.” Marks then responds to Cohn and
her CDC colleague, Sarah Mbaeyi, “I can live with this too. Please let me know if
you want to connect about the adverse event issue later today. Seems like work
is still ongoing, but let me know. Thanks.”
Cohn replies, “We have a meeting with Rochelle [presumably CDC Director
Rochelle Walensky] at 3:30 about if we should say anything or wait until we
have more definitive information. I will let you know where we land. I’m not sure
there is a right answer.””
“It again took a lawsuit for the Biden administration to hand over, albeit heavily redacted,
information regarding the safety of the COVID vaccines that the public has every right to
know,” Fitton said in a news release. “This disturbing batch of new documents have
uncovered a secret confidentiality agreement tied to COVID vaccine safety issues and
emails that raise new questions about the vaccines and pregnancy.”
Pfizer Hid Data on Lack of Effectiveness
After initially claiming in late 2020 that its COVID-19 shots were 95% effective, Pfizer’s
COVID shots turned out to have rapidly waning protection of just 39%. That figure was
reported in July 2021 by the Israeli Ministry of Health. Pfizer echoed the “declining
trend in vaccine efficacy” in late July 2021, but regulatory filings from April 2021 show
Pfizer knew of the shots’ failures months earlier. 6,7,8,9,10
“It’s clear from the documents that these analyses were almost 4 months old by the time
they became public,” Peter Doshi, associate professor at the University of Maryland
School of Pharmacy, told Maryanne Demasi, Ph.D., a former medical scientist with the
University of Adelaide and former reporter for ABC News in Australia.
“It’s disappointing that neither Pfizer, nor regulators, disclosed these data until it was too
obvious to ignore new outbreaks in Israel and Massachusetts, which made it clear that
vaccine performance was not holding up,” he said. Even Pfizer’s six-month phase III
trial data, released April 1, 2021, stayed silent on the shots’ waning efficacy.
And, at that time, health officials were still claiming that the shot would stop COVID-19
transmission. In May 2021, Dr. Anthony Fauci stated “when you get vaccinated, you not
only protect your own health … you become a dead end to the virus.”
As Doshi explained, “Publicly disclosing that efficacy waned so soon after authorization
might have undermined the credibility of authorities, who’d been projecting great
confidence about the vaccines’ ability to end the pandemic.” But instead of
transparency and supporting informed consent so Americans could make their own
choice about the shots with all the data, Demasi reported:
“Within weeks of Pfizer publishing its data on waning efficacy, President Biden
ordered all federal workers (and employees of contractors) to get vaccinated
within 75 days, otherwise they’d face punishment or have their employment
terminated.”
Shots’ Effects on Brain Known Since 2020
mRNA COVID-19 shots teach your cells to produce a protein, or piece of protein, that
triggers an immune response, including the production of antibodies. However,
because natural mRNA is easily broken down, this means the experimental gene therapy
needs a special delivery system to make it to the body’s cells.
The shots use lipid nanoparticles that contain polyethylene glycol (PEG) for this
purpose. The mRNA is wrapped in lipid nanoparticles (LNPs) that carry it to your cells, and the LNPs are “PEGylated” — that is, chemically attached to PEG molecules to
increase stability.
Usually, if you were to inject RNA into your body, enzymes would immediately break it
apart, but the COVID-19 shots are specifically designed so that doesn’t happen. While it
was originally advertised that COVID-19 shots “stay in the arm,” Pfizer knew since at
least November 2020 that the shots may influence the brain.
Pfizer contracted Acuitas Therapeutics to conduct animal studies, which found LNPs
from COVID-19 shots rapidly traveled to other areas, including the brain, eyes, heart,
ovaries and other organs. Naturopath Colleen Huber explained:
“Now that we have LNPs with their mRNA payload delivered past the BBB and
into the brain, what do they do once they arrive to the fluid surrounding
neurons? The rest is an easy journey for LNPs. Neurons take up LNPs — and
they do so very efficiently, at 100 percent uptake, by means of apolipoprotein E,
and usually without immune reaction at that point.
Apolipoprotein E is abundant in the brain — it is produced by astrocytes. The
mechanism of uptake is endocytosis, in which the membrane of the neuron
engulfs or swallows the approaching LNP. That has been observed since at
least 2013. In this way, the Trojan Horse content of the LNP is delivered,
because it was contained in a benign-seeming — to the neuronal membrane —
package.”
A number of neurological injuries have been reported following COVID-19 shots,
including ischemic stroke, Bell’s palsy, tinnitus and Guillain-Barré Syndrome. As for one
mechanism of brain injury, Stephanie Seneff, a senior research scientist at the
Massachusetts Institute of Technology (MIT), believes genetic modifications introduced
by COVID-19 shots may induce immune cells to release large quantities of exosomes
into circulation.
Exosomes are extracellular vesicles that contain protein, DNA, RNA and other
constituents, and may contain mRNA along with spike protein. According to Seneff ad colleagues:
“[W]e present the evidence that vaccination, unlike natural infection, induces a
profound impairment in type I interferon signaling, which has diverse adverse
consequences to human health.
We explain the mechanism by which immune cells release into the circulation
large quantities of exosomes containing spike protein along with critical
microRNAs that induce a signaling response in recipient cells at distant sites.
We also identify potential profound disturbances in regulatory control of protein
synthesis and cancer surveillance. These disturbances are shown to have a
potentially direct causal link to neurodegenerative disease, myocarditis,
immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive
immunity, increased tumorigenesis, and DNA damage.”
COVID Shots Melting Muscles
Preclinical studies for Pfizer’s COVID shots also warned of rhabdomyolysis, which is the
breakdown of skeletal muscles. Writing in DailyClout, Dr. Robert Chandler reported:
“The Pfizer documents contain results from a 17-day study of repeat dose
injections of BNT162b2 [Pfizer’s COVID-19 shot] in Wistar Han rats.
Myonecrosis and inflammation were identified histopathologically. The
appearance was described as “Jellied” (Table 3), which is what rhabdomyolysis
might look like after 17 days.”
Despite this and other concerning findings, including fibrosis, inflammation and
myofiber degeneration present at the injection site, Chandler explains, “How was this
data presented at the December 10, 2020, Vaccines and Related Biological Products
Advisory Committee (VRBPAC) meeting regarding the Emergency Use Authorization for
BNT162b2? … Completed with no safety concerns.”
A review of data from the U.S. Vaccine Adverse Events Reporting System (VAERS) also
revealed a dramatic increase in reports of rhabdomyolysis following the rollout of
COVID-19 shots. In fact, Chandler reveals:
“79% of all reported rhabdomyolysis cases occurred in the two complete years
(2021 and 2022) after the EUA was approved in December of 2020 … A
dramatic, 37-fold increase in the annual rate of cases of rhabdomyolysis
occurred after mass inoculation with Spike Producing Genetic Therapy
Products began in December 2020. COVID-19 (2020) did not cause an increase
in rhabdomyolysis reporting in VAERS compared with years 2001-2020.”
A number of case reports have since been published of “COVID-19 mRNA vaccination-
induced rhabdomyolysis,” including in a 16-year-old male two days after his first dose of
Pfizer’s COVID-19 shot and a 21-year-old male one day after his first COVID-19 shot.
The findings that Pfizer and government officials were aware of serious adverse events
and waning effectiveness of COVID-19 shots but neglected to share this with the public
will only further undermine trust in public health authorities.
As Martin Kulldorff — co-author of the Great Barrington Declaration, which scientifically
critiqued the effects of prolonged lockdowns in response to COVID-19 — told Demasi,
“In public health, it is important to be honest with the public. Pfizer should have reported
the declining vaccine efficacy in its April 1, 2021, press release, which they clearly knew
about at the time.”
Likewise with the numerous reports of adverse events linked to the shots, which have
now been linked to an explosion of excess deaths.
Sources and References
Judicial Watch February 10, 2023
Judicial Watch February 7, 2023
Just the News February 16, 2023
Substack, Maryanne Demasi, reports April 4, 2023
CNBC July 23, 2021
26
27 28
29
1, 3, 5, 6, 7
2
4
8, 11, 12
9
medRxiv July 28, 2021
Pfizer April 1, 2021
Twitter, Maryanne Demasi April 4, 2023
U.S. CDC December 18, 2020
Anthrax Vaccine January 11, 2021
Science December 21, 2020
From the Trenches World Report April 16, 2023
Acuitas Therapeutics. Final Report: Test facility study No. 185350, Sponsor ref No. ALC-NC-0552. Nov 9,
2020
Research Gate January 2022
Daily Clout April 14, 2023
Report No. 38166 July 1, 2020
Pediatr Nephrol. 2022 Nov 21 : 1–5
Diabetes Metab Syndr. 2021 July-August; 15(4): 102170
